Pillstats
Rx only · Tablet · Oral

Thyroid

Brands: Amerithroid · Thyroid

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US18 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC—
RxCUI (US)10572
US makers3 labelers
Packages18
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 10 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.233$0.467$0.700$0.934Dec 2025Apr 2026Jul 2026
$0.796
Latest avg · Jul 22, 2026
-2%
Since Dec 17, 2025
3
Active US suppliers
72%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2.9K5.7K8.6K11K2025 Q12025 Q22025 Q32025 Q42026 Q1
9.1K
Rx · 2026 Q1
438K
Units dispensed
+29%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Oliva Therapeutics, LLCunknown8SUPPLYING
ANI Pharmaceuticals, Inc.unknown5SUPPLYING
Vitruvias Therapeuticsunknown5SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.